Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Tiny stem cell companies close in on major heart disease goals

      Tiny stem cell companies close in on major heart disease goals

      Ruby Khatun Khatun20 Dec 2017 9:30 AM IST
      NEW YORK: The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes has given way to a long list of...
      NPPA notifies prices of 65 essential formulations

      NPPA notifies prices of 65 essential formulations

      Ruby Khatun Khatun19 Dec 2017 5:11 PM IST
      New Delhi: National drug pricing regulator NPPA said it has notified prices of 65 essential formulations, including those used for the treatment of...
      Dr Reddys settles US probe for 5 million dollars

      Dr Reddy's settles US probe for 5 million dollars

      Ruby Khatun Khatun19 Dec 2017 11:44 AM IST
      Dr Reddy’s Laboratories Ltd will pay $5 million to resolve the U.S. claims that the Indian company sold prescription drugs in the United States in...
      Indian firm gets drug controller nod for phase-I clinical trial of Zika vaccine

      Indian firm gets drug controller nod for phase-I clinical trial of Zika vaccine

      Ruby Khatun Khatun19 Dec 2017 11:00 AM IST
      New Delhi: The Drugs Controller General (India) has granted permission to an Indian firm to conduct Phase-I clinical trial, in pursuance to its...
      Cost standardization in health insurance need of hour: T S Vijayan

      Cost standardization in health insurance need of hour: T S Vijayan

      Ruby Khatun Khatun19 Dec 2017 10:30 AM IST
      New Delhi: IRDAI chief T S Vijayan batted for cost standardisation in health insurance, saying the cost should be comparable at least locally or...
      Roche, Shire court fight escalates over haemophilia drug

      Roche, Shire court fight escalates over haemophilia drug

      Ruby Khatun Khatun19 Dec 2017 10:15 AM IST
      ZURICH: Roche’s patent dispute with London-listed Shire over the Swiss drugmaker’s new haemophilia drug Hemlibra has escalated, with Shire filing a...
      Allergan, Richters bipolar depression drug succeeds in key trial

      Allergan, Richter's bipolar depression drug succeeds in key trial

      Ruby Khatun Khatun19 Dec 2017 10:00 AM IST
      Allergan Plc and Hungary’s Gedeon Richter Plc said on Monday their drug to treat severe bipolar depression in adults met the main goal of a late-stage...
      FDA allows Alnylam to restart hemophilia treatment trials

      FDA allows Alnylam to restart hemophilia treatment trials

      Ruby Khatun Khatun19 Dec 2017 9:45 AM IST
      The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a rare...
      FDA launches new tool for sharing information that allows doctors to better manage antibiotic use

      FDA launches new tool for sharing information that allows doctors to better manage antibiotic use

      Ruby Khatun Khatun19 Dec 2017 9:30 AM IST
      The U.S. Food and Drug Administration (FDA) is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to...
      Indian online pharmacy huge health risk: Pharma Body

      Indian online pharmacy huge health risk: Pharma Body

      Ruby Khatun Khatun18 Dec 2017 4:08 PM IST
      New Delhi: Indian pharmacists fear rise in self-medication and abuse unless online drug sales are checked.In the run-up to the 69th Indian...
      Fortis Healthcare rejects over pricing of drugs charge

      Fortis Healthcare rejects over pricing of drugs charge

      Ruby Khatun Khatun18 Dec 2017 11:00 AM IST
      New Delhi: Fortis Healthcare has rejected charges of overpricing the medicines that it is giving to its patients.In a statement, it said, "Fortis...
      Novo Nordisk wins EU panel

      Novo Nordisk wins EU panel's backing for key diabetes drug

      Ruby Khatun Khatun18 Dec 2017 10:30 AM IST
      COPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok